Survival and predictive factors in dialysis patients with COVID-19 in Japan: a nationwide cohort study.

Kan KikuchiMasaomi NangakuMunekazu RyuzakiTomoyuki YamakawaOota YoshihiroNorio HanafusaKen SakaiYoshihiko KannoRyoichi AndoToshio ShinodaHidetomo NakamotoTadao Akizawanull null

Published in: Renal replacement therapy (2021)

Dialysis patients have a high severity of illness and a high risk of mortality in cases of COVID-19. Treatment with remdesivir might be effective in shortening the duration of hospitalization and reducing the risk of mortality.

Keyphrases

end stage renal disease
chronic kidney disease
peritoneal dialysis
cardiovascular events
ejection fraction
coronavirus disease
sars cov
newly diagnosed
risk factors
prognostic factors
type diabetes
cardiovascular disease
coronary artery disease
patient reported outcomes